News today that is likely a bio similar for aflibercept will be allowed by the courts in the USA. Does this make Opthea more vulnerable as a combination injection for Regeneron, ie Regeneron make a new combined injection?
biosimilar aflibercept possibly imminent, Opthea more valuable to Regeneron?
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
77.8¢ |
Change
-0.013(1.58%) |
Mkt cap ! $929.4M | |||
| Open | High | Low | Value | Volume |
| 79.0¢ | 79.0¢ | 74.5¢ | $687.2K | 897.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 19 | 17312 | 77.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 78.0¢ | 27141 | 19 |
View Market Depth
| Last trade - 12.26pm 27/09/2024 (20 minute delay) ? |
| OPT (ASX) Chart |